https://wiki.creativecommons.org/api.php?action=feedcontributions&user=Mike.moench8&feedformat=atomCreative Commons - User contributions [en]2024-03-28T19:16:41ZUser contributionsMediaWiki 1.30.0https://wiki.creativecommons.org/index.php?title=Case_Studies/GlaxoSmithKline&diff=79795Case Studies/GlaxoSmithKline2013-08-11T07:50:12Z<p>Mike.moench8: /* Media */</p>
<hr />
<div>{{Case Study<br />
|Description=GlaxoSmithKline is a major pharmaceutical company that has surrendered all copyrights in its malarial data set, which includes more than 13,500 compounds known to be active against malaria.<br />
|Mainurl=http://www.ebi.ac.uk/chemblntd/#tcams_dataset<br />
|Author=ChEMBL-NTD, GlaxoSmithKline<br />
|User_Status=Curator, Creator<br />
|Tag=GSK, GlaxoSmithKline, malaria, disease<br />
|License short name=GNU GPL<br />
|Format=Image, Sound, Text, MovingImage, InteractiveResource, Other, Geodata, Data<br />
|Country=United Kingdom<br />
|Quote=Providing access to this level of information sees GSK set what I would hope to be a new trend that could revolutionise the urgent search for new medicines to tackle malaria. By sharing data, we start to build up a public database of knowledge that should be as powerful as the human genome databases.<br />
|Quote_Attribution=Timothy Wells, Chief Scientific Officer of the Medicines for Malaria Venture (http://www.gsk.com/responsibility/access/rnd-neglected-tropical-diseases.htm)<br />
|Image_Header=http://wiki.creativecommons.org/images/0/04/Logo-gsk.gif<br />
|Image_attribution=(c) GSK<br />
|Image_license=http://www.gsk.com/terms.htm<br />
|importance=High<br />
|quality=B-Class<br />
|License_short_name=CC0<br />
}}<br />
== Overview ==<br />
One of the leading pharmaceutical companies in the world, GlaxoSmithKline has surrendered all copyrights in its malarial data set, which includes more than 13,500 compounds known to be active against malaria. The data set is called Tres Cantos Antimalarial (TCAMS), and is available from the ChEMBL-NTD database, "a repository for Open Access primary screening and medicinal chemistry data directed at neglected diseases - endemic tropical diseases of the developing regions of the Africa, Asia, and the Americas."<br />
<br />
== License Usage ==<br />
<br />
GlaxoSmithKline has surrendered all copyright in its malaria data set under the CC0 public domain dedication.<br />
<br />
== Motivations ==<br />
From GSK's http://www.gsk.com/responsibility/downloads/GSK-CR-2009-full.pdf<br />
<br />
<blockquote>"By making this information publicly available, GSK hopes that many other scientists will review this information and analyse the data faster than we could on our own. Hopefully, this will lead to additional research that could help drive the discovery of new medicines. We would also encourage other groups, including academics and pharmaceutical companies, to make their own compounds and related information publicly available.<br />
<br />
<br/><br/>This is essentially an example of ‘open source’ being applied to drug discovery. We know that data increases in value when connected with other data and that the more eyes looking at a problem, the more potential solutions may arise."</blockquote><br />
<br />
Research and development (R&D) for diseases prevalent in the developing world are costly and time-consuming and carry less return on investment than R&D for diseases, such as HIV/AIDS, which have a market in the developed world. Since malaria is a disease that primarily affects the developing world, GSK has released malarial data in order to speed the process of R&D, while providing resources that nonprofits and academic institutions don't necessarily have wide access to, such as advanced technologies, facilities for medicinal drug discovery, and manufacturing and distribution expertise. For more information, see GSK's 2009 [http://watersoftenerreviewspro.com/ report on]<br />
<br />
== Media ==<br />
[http://www.nature.com/news/2010/100120/full/news.2010.20.html Nature - GlaxoSmithKline goes public with malaria data]<br />
<br/><br />
[http://www.guardian.co.uk/science/2010/jan/20/glaxo-malaria-drugs-public-domain The Guardian - Glaxo offers free access to potential malaria cures]<br />
<br/><br />
[http://www.gsk.com/media/malaria.htm GSK's commitment to fighting Malaria]<br />
<br/><br />
[http://hyperfuel9x.us/ hyper fuel 9x]<br />
<br/><br />
[http://www.gsk.com/media/pressreleases/2010/2010_pressrelease_10009.htm press release]</div>Mike.moench8https://wiki.creativecommons.org/index.php?title=Case_Studies/GlaxoSmithKline&diff=78238Case Studies/GlaxoSmithKline2013-08-03T02:08:57Z<p>Mike.moench8: /* Media */</p>
<hr />
<div>{{Case Study<br />
|Description=GlaxoSmithKline is a major pharmaceutical company that has surrendered all copyrights in its malarial data set, which includes more than 13,500 compounds known to be active against malaria.<br />
|Mainurl=http://www.ebi.ac.uk/chemblntd/#tcams_dataset<br />
|Author=ChEMBL-NTD, GlaxoSmithKline<br />
|User_Status=Curator, Creator<br />
|Tag=GSK, GlaxoSmithKline, malaria, disease<br />
|License short name=GNU GPL<br />
|Format=Image, Sound, Text, MovingImage, InteractiveResource, Other, Geodata, Data<br />
|Country=United Kingdom<br />
|Quote=Providing access to this level of information sees GSK set what I would hope to be a new trend that could revolutionise the urgent search for new medicines to tackle malaria. By sharing data, we start to build up a public database of knowledge that should be as powerful as the human genome databases.<br />
|Quote_Attribution=Timothy Wells, Chief Scientific Officer of the Medicines for Malaria Venture (http://www.gsk.com/responsibility/access/rnd-neglected-tropical-diseases.htm)<br />
|Image_Header=http://wiki.creativecommons.org/images/0/04/Logo-gsk.gif<br />
|Image_attribution=(c) GSK<br />
|Image_license=http://www.gsk.com/terms.htm<br />
|importance=High<br />
|quality=B-Class<br />
|License_short_name=CC0<br />
}}<br />
== Overview ==<br />
One of the leading pharmaceutical companies in the world, GlaxoSmithKline has surrendered all copyrights in its malarial data set, which includes more than 13,500 compounds known to be active against malaria. The data set is called Tres Cantos Antimalarial (TCAMS), and is available from the ChEMBL-NTD database, "a repository for Open Access primary screening and medicinal chemistry data directed at neglected diseases - endemic tropical diseases of the developing regions of the Africa, Asia, and the Americas."<br />
<br />
== License Usage ==<br />
<br />
GlaxoSmithKline has surrendered all copyright in its malaria data set under the CC0 public domain dedication.<br />
<br />
== Motivations ==<br />
From GSK's http://www.gsk.com/responsibility/downloads/GSK-CR-2009-full.pdf<br />
<br />
<blockquote>"By making this information publicly available, GSK hopes that many other scientists will review this information and analyse the data faster than we could on our own. Hopefully, this will lead to additional research that could help drive the discovery of new medicines. We would also encourage other groups, including academics and pharmaceutical companies, to make their own compounds and related information publicly available.<br />
<br />
<br/><br/>This is essentially an example of ‘open source’ being applied to drug discovery. We know that data increases in value when connected with other data and that the more eyes looking at a problem, the more potential solutions may arise."</blockquote><br />
<br />
Research and development (R&D) for diseases prevalent in the developing world are costly and time-consuming and carry less return on investment than R&D for diseases, such as HIV/AIDS, which have a market in the developed world. Since malaria is a disease that primarily affects the developing world, GSK has released malarial data in order to speed the process of R&D, while providing resources that nonprofits and academic institutions don't necessarily have wide access to, such as advanced technologies, facilities for medicinal drug discovery, and manufacturing and distribution expertise. For more information, see GSK's 2009 [http://watersoftenerreviewspro.com/ report on]<br />
<br />
== Media ==<br />
[http://www.nature.com/news/2010/100120/full/news.2010.20.html Nature - GlaxoSmithKline goes public with malaria data]<br />
<br/><br />
[http://www.guardian.co.uk/science/2010/jan/20/glaxo-malaria-drugs-public-domain The Guardian - Glaxo offers free access to potential malaria cures]<br />
<br/><br />
[http://www.gsk.com/media/malaria.htm GSK's commitment to fighting Malaria]<br />
<br/><br />
http://musclezx90.blogspot.com/<br />
<br/><br />
[http://hyperfuel9x.us/ hyper fuel 9x]<br />
<br/><br />
[http://www.gsk.com/media/pressreleases/2010/2010_pressrelease_10009.htm press release]</div>Mike.moench8https://wiki.creativecommons.org/index.php?title=Case_Studies/Revver_Study&diff=78237Case Studies/Revver Study2013-08-03T02:06:35Z<p>Mike.moench8: /* Motivations */</p>
<hr />
<div>{{Case Study<br />
|importance=High<br />
|quality=A-Class<br />
|Description=Revver self-describes as being ‘a powerful platform and suite of tools for serving and sharing media’ whilst forming a community of video lovers and artists who share in the site’s profits through its advertising structure.<br />
|Quote=Revver is an online media network built the way the internet really works. We support the free and unlimited sharing of media. Our unique technology pairs videos with targeted ads and tracks them as they spread across the web. So no matter where your video travels, you benefit because we share the advertising revenue with you.<br />
|Quote_Attribution=http://www.revver.com/about/<br />
|Image_Header=http://www.tvover.net/content/binary/Revver_logo.jpg<br />
|Mainurl=http://www.revver.com/<br />
|Author=Revver<br />
|User_Status=Curator<br />
|Tag=videos, advertising, business model<br />
|License_short_name=CC BY-NC-ND<br />
|License=http://creativecommons.org/licenses/by-nc-nd/2.5/<br />
|Format=MovingImage<br />
|Country=Global<br />
}}<br />
== Overview ==<br />
[http://www.revver.com/ Revver] is a video-sharing platform deploying an innovative business model with hyperdistribution as its core. Differentiating itself from competitor YouTube by offering per-view revenue, the platform takes advantage of peer-to-peer distribution mechanisms for sharing its hosted videos. When a user uploads a video to Revver, customised software inserts a brief, unobtrusive advertisement at the end of the video stream. At this point, the ‘Revverised’ video can be downloaded and distributed via any method – website, email, P2P, without losing the advertisement. Revver software reports back to the main website every time the embedded ad is clicked irrespective of location, prompting the advertiser to be charged a micropayment. The platform shares the associated revenue with the owner of the video on a 50/50 basis. Revver’s users are able to track their video’s performance, monitoring how many times the video has been viewed, and the amount of revenue accruing. Sharers are able to earn 20% of ad revenue for forwarding the videos. Revver is therefore founded on the ‘free and unlimited sharing of content online in an environment where the creator is rewarded for his/her work.’<br />
<br />
== License Usage ==<br />
:‘Copyright is complicated stuff. Our position on it is pretty simple.’ http://www.revver.com/go/copyright/<br />
<br />
Revver’s business model is particularly noteworthy as it aims to take the wide-spread sharing of copyright material that occurs online and turn it into an asset, rather than a reason for litigation. The site uses Creative Commons Attribution-Noncommercial-NoDerivatives licences to permit users to distribute their content (with embedded advertising) verbatim for non-commercial purposes. The only additional requirement is that the creator of the video is attributed alongside Revver as host. This revenue-raising strategy not only permits widespread distribution; it relies on it – the more people who see the video, the more money both the site and the creator earn. <br />
<br />
Adherence to copyright law is an important issue for Revver. All uploaded videos are reviewed by a human before being made available online. Reviewers look for copyright violations, fraudulent tagging, and any inappropriate content which would violate the site’s member agreement, such as content deemed obscene or hateful. If the site’s reviewers detect possible copyright violations, the uploader is emailed, and asked to document their ownership of the item in question, be it the video footage, background music or other content. Revver’s copyright statement declares: <br />
<br />
:‘At Revver, we staunchly support copyright laws. Our mission and business is firmly rooted in the idea that artists deserve to control and be rewarded from their intellectual property. We also believe strongly in the protections provided by the doctrine of Fair Use, which is part of US copyright law, and to comparable protections provided under the copyright laws in other jurisdictions. While it is impossible to draw a hard and fast line between what is Fair Use and what is not, we understand that we are living in a remix culture and we support an open media environment that allows creators to lawfully build on the work of earlier creators.’<br />
<br />
== Motivations ==<br />
Recognised as an early adopter of next-generation business models, Revver is underpinned by [http://revver.com/go/faq/ the belief] that ‘a free and open, democratized media environment is good for everyone. Our goal is to empower video makers and sharers to do what they do best.’ <br />
<br />
Support for the balance in copyright law, and alternative options including Creative Commons is further evidenced in Revver’s support for open source communities. Revver acknowledges that they have built their products with a number of open source software projects including Python, Twisted, mySQL, PostgreSQL, Xen, Java, PHP, Apache, Lighttpd, and Django. In return, Revver has made the ‘ActiveRevver‘ and ‘Sparkline’ pieces of software available for usage, modification, and distribution under the MIT licence. Revver’s Developer Centre provides access to the Application Programming Interface (API), involving software developers in the enhancement of the platform.<br />
<br />
Given the sharing environment established by Revver, Creative Commons used the [http://www.geodesicdomehomes.net platform] during its initial [http://creativecommons.org/weblog/entry/6125 fall fundraising campaign] in 2006 with the video [http://support.creativecommons.org/videos#wwt ''Wanna Work Together''], which they encouraged supporters to embed in their sites.<br />
<br />
== Media ==<br />
<script src="http://flash.revver.com/player/1.0/player.js?mediaId:89072;width:480;height:392;" type="text/javascript"></script></div>Mike.moench8https://wiki.creativecommons.org/index.php?title=Case_Studies/Revver_Study&diff=78236Case Studies/Revver Study2013-08-03T02:05:17Z<p>Mike.moench8: /* License Usage */</p>
<hr />
<div>{{Case Study<br />
|importance=High<br />
|quality=A-Class<br />
|Description=Revver self-describes as being ‘a powerful platform and suite of tools for serving and sharing media’ whilst forming a community of video lovers and artists who share in the site’s profits through its advertising structure.<br />
|Quote=Revver is an online media network built the way the internet really works. We support the free and unlimited sharing of media. Our unique technology pairs videos with targeted ads and tracks them as they spread across the web. So no matter where your video travels, you benefit because we share the advertising revenue with you.<br />
|Quote_Attribution=http://www.revver.com/about/<br />
|Image_Header=http://www.tvover.net/content/binary/Revver_logo.jpg<br />
|Mainurl=http://www.revver.com/<br />
|Author=Revver<br />
|User_Status=Curator<br />
|Tag=videos, advertising, business model<br />
|License_short_name=CC BY-NC-ND<br />
|License=http://creativecommons.org/licenses/by-nc-nd/2.5/<br />
|Format=MovingImage<br />
|Country=Global<br />
}}<br />
== Overview ==<br />
[http://www.revver.com/ Revver] is a video-sharing platform deploying an innovative business model with hyperdistribution as its core. Differentiating itself from competitor YouTube by offering per-view revenue, the platform takes advantage of peer-to-peer distribution mechanisms for sharing its hosted videos. When a user uploads a video to Revver, customised software inserts a brief, unobtrusive advertisement at the end of the video stream. At this point, the ‘Revverised’ video can be downloaded and distributed via any method – website, email, P2P, without losing the advertisement. Revver software reports back to the main website every time the embedded ad is clicked irrespective of location, prompting the advertiser to be charged a micropayment. The platform shares the associated revenue with the owner of the video on a 50/50 basis. Revver’s users are able to track their video’s performance, monitoring how many times the video has been viewed, and the amount of revenue accruing. Sharers are able to earn 20% of ad revenue for forwarding the videos. Revver is therefore founded on the ‘free and unlimited sharing of content online in an environment where the creator is rewarded for his/her work.’<br />
<br />
== License Usage ==<br />
:‘Copyright is complicated stuff. Our position on it is pretty simple.’ http://www.revver.com/go/copyright/<br />
<br />
Revver’s business model is particularly noteworthy as it aims to take the wide-spread sharing of copyright material that occurs online and turn it into an asset, rather than a reason for litigation. The site uses Creative Commons Attribution-Noncommercial-NoDerivatives licences to permit users to distribute their content (with embedded advertising) verbatim for non-commercial purposes. The only additional requirement is that the creator of the video is attributed alongside Revver as host. This revenue-raising strategy not only permits widespread distribution; it relies on it – the more people who see the video, the more money both the site and the creator earn. <br />
<br />
Adherence to copyright law is an important issue for Revver. All uploaded videos are reviewed by a human before being made available online. Reviewers look for copyright violations, fraudulent tagging, and any inappropriate content which would violate the site’s member agreement, such as content deemed obscene or hateful. If the site’s reviewers detect possible copyright violations, the uploader is emailed, and asked to document their ownership of the item in question, be it the video footage, background music or other content. Revver’s copyright statement declares: <br />
<br />
:‘At Revver, we staunchly support copyright laws. Our mission and business is firmly rooted in the idea that artists deserve to control and be rewarded from their intellectual property. We also believe strongly in the protections provided by the doctrine of Fair Use, which is part of US copyright law, and to comparable protections provided under the copyright laws in other jurisdictions. While it is impossible to draw a hard and fast line between what is Fair Use and what is not, we understand that we are living in a remix culture and we support an open media environment that allows creators to lawfully build on the work of earlier creators.’<br />
<br />
== Motivations ==<br />
Recognised as an early adopter of next-generation business models, Revver is underpinned by [http://revver.com/go/faq/ the belief] that ‘a free and open, democratized media environment is good for everyone. Our goal is to empower video makers and sharers to do what they do best.’ <br />
<br />
Support for the balance in copyright law, and alternative options including Creative Commons is further evidenced in Revver’s support for open source communities. Revver acknowledges that they have built their products with a number of [http://www.revver.com/go/faq/#api1 open source software projects] including Python, Twisted, mySQL, PostgreSQL, Xen, Java, [http://www.anggarakasa.com PHP], Apache, Lighttpd, and Django. In return, Revver has made the ‘ActiveRevver‘ and ‘Sparkline’ pieces of software available for usage, modification, and distribution under the MIT licence. [http://developer.revver.com/ Revver’s Developer Centre] provides access to the Application Programming Interface (API), involving software developers in the enhancement of the platform.<br />
<br />
Given the sharing environment established by Revver, Creative Commons used the [http://www.geodesicdomehomes.net platform] during its initial [http://creativecommons.org/weblog/entry/6125 fall fundraising campaign] in 2006 with the video [http://support.creativecommons.org/videos#wwt ''Wanna Work Together''], which they encouraged supporters to embed in their sites.<br />
<br />
== Media ==<br />
<script src="http://flash.revver.com/player/1.0/player.js?mediaId:89072;width:480;height:392;" type="text/javascript"></script></div>Mike.moench8